Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 251-459-0 | CAS number: 33329-35-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The substance is severely irritating and corrosive to the skin, eyes and respiratory tract.
No thresholds are definable for the corrosive/irritant effects.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No GLP
- Qualifier:
- no guideline followed
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- not specified
- Principles of method if other than guideline:
- Non GLP toxicity study.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- other: Rat and Mouse
- Sex:
- male/female
- Route of administration:
- oral: drinking water
- Vehicle:
- water
- Control animals:
- not specified
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 2.81 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- > 2.34 - <= 3.26
- Interpretation of results:
- sligthly toxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Rat - Acute Oral LD50 = 2385 mg/kg
Mouse - Acute Oral LD50 = 2597 mg/kg
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 385 mg/kg bw
- Quality of whole database:
- The substance is severely irritating and corrosive to the skin, eyes and respiratory tract. Limited conclusions regarding systemic toxicity are possible due to the corrosive effects observed in animals (forestomach corrosion, low urinary pH, clinical indications).
Rat - Acute Oral LD50 = 2385 mg/kg
Mouse - Acute Oral LD50 = 2597 mg/kg
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No GLP
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Groups of five male and five female rats were exposed for four hours in a 160-liter glass and stainless steel chamber to vapors and aerosols of ABBOTT-48832. The highest feasible nominal concentration was 22,5mg/L (actual concentration was not determined at this level). Both nominal and actual exposure concentrations were determined for the LC50 study. The exposure concentrations were as follows :
Actual Concentration Nominal Concentration
(mg/L) (mg/L)
1.1 3.6
1.7 6.3
2.3 8.3
2.4 9.6
2.8 11.3
Aerosols of the test material were generated by metering the liquid with a FMI pump into a spraying system atomizer. An air pressure of 10 psig with an airflow rate of 8 or 10 L/min was applied to the atomizer which aerosolized the liquid for rapid vaporization.
The vapors and aerosols emerging from the atomizer were diluted by the incoming chamber air to the desired concentration.
The size range of aerosol particles was 3.1 + 1.9 mcm.
Observations for signs of toxicity and mortality were made during the 4-hour exposure period and twice daily thereafter for 14 days.
Body weights were recorded on days 0 (prior to exposure), 1, 3, 7 and 14.
Animals that died during the study were necropsied. The surviving animals were necropsied at the end of the 14-day observation period. - GLP compliance:
- no
- Test type:
- fixed concentration procedure
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- other: Inhalation - vapour and aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- Aerosols of the test material were generated by metering the liquid with a FMI pump into a spraying system atomizer. An air pressure of 10 psig with an airflow rate of 8 or 10 L/min was applied to the atomizer which aerosolized the liquid for rapid vaporization.
The vapors and aerosols emerging from the atomizer were diluted by the incoming chamber air to the desired concentration. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- ca. 4 h
- Concentrations:
- Actual Nominal
(mg/L) (mg/L)
1.1 3.6
1.7 6.3
2.3 8.3
2.4 9.6
2.8 11.3 - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 2 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- 1.8 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- Up to 0-100% mortality in dosed groups.
- Clinical signs:
- other: Clinical signs observed were dyspnea, nasal discharge, salivation, evidence of red matter around the face, alopecia and dermal irritation.
- Body weight:
- All animals exposed demonstrated body weight loss sometime during the first week of the postexposure period.
- Gross pathology:
- At necropsy red lungs were observed in a few animals from each group. Scattered red patches on the lungs were also observed in a few animals from each group with the exception of Group 111, where the lesion was not observed. Black patches in the thymus was observed in three males and three females during the necropsy.
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the nominal concentrations the calculated 4-hour LC50 for males was 7.4 mg/L, while for the females it was 6.4 mg/L. In terms of actual concentrations, the 4-hour LC50 for males was 2.0 mg/L, while for the females it was 1.8 mg/L.
- Executive summary:
Both nominal and actual exposure concentrations were determined for the LC50 study. Nominal concentrations were determined by weighing the amount of test material placed in the generator reservoir prior to exposure and then again following exposure. The difference in weight was divided by the total air passed through the chamber during the exposure period. Actual exposure concentrations were determined by standard gravimetric techniques.
The results indicated that nominal concentrations were higher than actual concentrations, e.g. 11.3 mg/L versus 2.8 mg/L for the highest concentration. Since B.P.>200°C, and vapour pressure=0.172 lb/inch3) this is a liquid material with low volatility, the actual measured concentrations seem more appropriate for evaluation of toxicity.
In conclusion, at actual exposure concentrations of 1.1-2.8 mg/L (nominal concentrations of 3.6-11.3 mg/L) for four hours produced signs of toxicity and deaths in rats. The combined male and female 4-hour LC50 values for actual measured concentrations and nominal concentrations were estimated to be 1.9 mg/L and 6.9 mg/L, respectively.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 1.8 mg/m³ air
- Quality of whole database:
- The substance is severely irritating and corrosive to the skin, eyes and respiratory tract.
At necropsy red lungs were observed in a few animals from each group. Scattered red patches on the lungs were also observed in a few animals from each group with the exception of Group 111, where the lesion was not observed. Black patches in the thymus was observed in three males and three females during the necropsy.
Limited conclusions regarding systemic toxicity are possible due to the corrosive effects observed in animals (lung injury).
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: non-guidleine.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Male and female New Zealand albino rabbits3 weighing 2.06 to 2.97 kg each were used.
Before treatment, the back of each rabbit was clipped free of hair to prepare a site of application constituting approximately 10% of the total body surface area (approximately 150 to 250 square centimeters). Immediately before application of the test material, the treatment sites of half of the rabbits were further prepared by making four minor epidermal incisions at two to three centimeter intervals longi- tudinally over the area of exposure. Bleeding was not induced.
A single dose of the test material was applied evenly over the application site of each test rabbit. Groups of five males or five female were treated with dosages ranging from 0.86 to 2.00 mllkg. After application of the test material, the entire trunk of each animal was wrapped with a thin plastic film secured in place with tape and a gauze over-wrap.
Twenty-four hours later the wrapping was removed and excess test material was gently wiped (not washed) off the test site.
After treatment all animals were observed twice each day for two weeks for fatalities and signs of systemic toxicity. Local effects were recorded once each day. The body weights of all animals were recorded at the time of treatment, one week later, and at necropsy. - GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- The test material was applied topically to the shaved and intact or abraded skin at dosages ranging from 0.86 to 2.00 ml/kg. The test site was then covered with an occlusive plastic film for 24 hours.
- Duration of exposure:
- 24 hours
- Doses:
- 0.86 to 2.00 ml/kg.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent no treatment
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 120 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Unabraded skin
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 171 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Unabraded skin
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 400 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Abraded skin
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 976 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Abraded skin
- Gross pathology:
- POLYCAT 9 produced marked local irritation and corrosion.
- Other findings:
- POLYCAT 9 was very irritating, corrosive and systemically toxic when applied to the skin of rabbits. Local effects were not reversible within two weeks. Signs of systemic toxicity including hematuria, decreased activity and ataxia were observed at all dosages (0.86 to 2.00 ml/kg) for up to a week after treatment.
The minimum lethal dosage was 1.10 ml/kg and LD50 values ranged from 1.15 to 1.65 ml/kg. No sex-related differences in toxicity were observed. Also, abrading the skin prior to treatment did not appear to enhance the toxicity of the test material.
Signs of systemic toxicity including hematuria, decreased activity, ataxia and dyspnea were also observed. Liver discoloration and hemorrhagic changes in the stomach, lungs and kidneys were observed macroscopically and dermal necrosis and subcutaneous hemorrhages, edema and inflammation were observed microscopically in rabbits treated with POLYCAT 9. - Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Polycat 9 is severely irritating and corrosive to the skin, eyes and respiratory tract.
- Executive summary:
Male Rabbit LD50 1120 mg/kg (unabraded skin)
Female Rabbit LD50 1171 mg/kg (unabraded skin)
Male Rabbit LD50 1400 mg/kg (abraded skin)
Female Rabbit LD50 976 mg/kg (abraded skin)
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 976 mg/kg bw
- Quality of whole database:
- The substabnce is severely irritating and corrosive to the skin, eyes and respiratory tract. Limited conclusions regarding systemic toxicity are possible due to the corrosive effects observed in animals (forestomach corrosion, low urinary pH, clinical indications).
Male Rabbit LD50 1120 mg/kg (unabraded skin)
Female Rabbit LD50 1171 mg/kg (unabraded skin)
Male Rabbit LD50 1400 mg/kg (abraded skin)
Female Rabbit LD50 976 mg/kg (abraded skin)
Additional information
Acute oral toxicity study using the test substance.
Justification for selection of acute toxicity – inhalation endpoint
Acute inhalation toxicity study using the test substance.
Justification for selection of acute toxicity – dermal endpoint
Acute dermal toxicity study using the test substance.
Justification for classification or non-classification
The substance is severely irritating and corrosive to the skin, eyes and respiratory tract.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.